Stocks
LENZ Therapeutics Reports Q1 2026 Performance, Targets 15,000 HCPs
LENZ Therapeutics delivered Q1 2026 results consistent with expectations, achieving $1.9 million in net revenue and approximately 25,000 prescriptions. The company also...